• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Managing oral anticoagulant therapy.

作者信息

Ansell J, Hirsh J, Dalen J, Bussey H, Anderson D, Poller L, Jacobson A, Deykin D, Matchar D

机构信息

Department of Medicine, Boston University Medical Center, MA 02118, USA.

出版信息

Chest. 2001 Jan;119(1 Suppl):22S-38S. doi: 10.1378/chest.119.1_suppl.22s.

DOI:10.1378/chest.119.1_suppl.22s
PMID:11157641
Abstract
摘要

相似文献

1
Managing oral anticoagulant therapy.管理口服抗凝治疗。
Chest. 2001 Jan;119(1 Suppl):22S-38S. doi: 10.1378/chest.119.1_suppl.22s.
2
Moderate dose oral anticoagulant therapy in patients with the antiphospholipid syndrome? No.抗磷脂综合征患者的中等剂量口服抗凝治疗？不适用。
J Thromb Haemost. 2005 May;3(5):844-5. doi: 10.1111/j.1538-7836.2005.01405.x.
3
Moderate dose oral anticoagulant therapy in patients with the antiphospholipid syndrome? No.抗磷脂综合征患者使用中等剂量口服抗凝治疗？不适用。
J Thromb Haemost. 2005 May;3(5):842-3. doi: 10.1111/j.1538-7836.2005.01397.x.
4
Moderate dose oral anticoagulant therapy in patients with the antiphospholipid syndrome? Yes.抗磷脂综合征患者使用中等剂量口服抗凝治疗？答案是肯定的。
J Thromb Haemost. 2005 May;3(5):840-1. doi: 10.1111/j.1538-7836.2005.01396.x.
5
Variability in the international normalised ratio (INR) in patients with antiphospholipid syndrome and positive lupus anticoagulant: should the INR targets be higher?抗磷脂综合征且狼疮抗凝物阳性患者国际标准化比值（INR）的变异性：INR 目标值应更高吗？
BMJ Case Rep. 2015 Apr 9;2015:bcr2014209013. doi: 10.1136/bcr-2014-209013.
6
Analysis and occurrence of adverse events with oral anticoagulant therapy.口服抗凝治疗的不良事件分析与发生情况
Semin Thromb Hemost. 1999;25(1):65-71. doi: 10.1055/s-2007-996426.
7
[Recommended use of INR in the laboratory monitoring of oral anticoagulant treatment].
Duodecim. 1998;114(6):573-5.
8
Thromboembolic neurologic events in patients with antiphospholipid-antibody syndrome.抗磷脂抗体综合征患者的血栓栓塞性神经事件
Ital J Neurol Sci. 1999 Feb;20(1):3. doi: 10.1007/s100720050002.
9
[Monitoring of anticoagulation--management in practice].[抗凝监测——实践中的管理]
Dtsch Med Wochenschr. 2014 Jan;139 Suppl 1:S27-30. doi: 10.1055/s-0033-1359975. Epub 2014 Jan 20.
10
Non-vitamin K antagonist oral anticoagulants and antiphospholipid syndrome.非维生素K拮抗剂口服抗凝剂与抗磷脂综合征
Rheumatology (Oxford). 2016 Oct;55(10):1726-35. doi: 10.1093/rheumatology/kev445. Epub 2016 Feb 3.

引用本文的文献

1
Direct factor Xa inhibitors versus low molecular weight heparins or vitamin K antagonists for prevention of venous thromboembolism in elective primary hip or knee replacement or hip fracture repair.在择期初次髋关节或膝关节置换术或髋部骨折修复中，直接凝血因子Xa抑制剂与低分子量肝素或维生素K拮抗剂用于预防静脉血栓栓塞的比较
Cochrane Database Syst Rev. 2025 Jan 27;1(1):CD011762. doi: 10.1002/14651858.CD011762.pub2.
2
Warfarin overdose successfully treated using prophylactic vitamin K infusion without severe coagulopathy: A case report.使用预防性维生素K输注成功治疗华法林过量且无严重凝血病：一例报告
Acute Med Surg. 2025 Jan 9;12(1):e70036. doi: 10.1002/ams2.70036. eCollection 2025 Jan-Dec.
3
Exploring the association between atrial fibrillation and celiac disease: a comprehensive review.
探索心房颤动与乳糜泻之间的关联：一项综述
Ann Med Surg (Lond). 2024 Jun 10;86(12):7155-7163. doi: 10.1097/MS9.0000000000002259. eCollection 2024 Dec.
4
The 2023 WSES guidelines on the management of trauma in elderly and frail patients.2023 年 WSES 老年和虚弱患者创伤管理指南。
World J Emerg Surg. 2024 May 31;19(1):18. doi: 10.1186/s13017-024-00537-8.
5
Being precise with anticoagulation to reduce adverse drug reactions: are we there yet?精准抗凝以减少药物不良反应：我们做到了吗？
Pharmacogenomics J. 2024 Mar 5;24(2):7. doi: 10.1038/s41397-024-00329-y.
6
Effectiveness and Health Outcomes of Collaborative Nurse Prescribing for Patients Anticoagulated with Antivitamin K in Primary Care: A Study Protocol.初级保健中接受抗维生素K抗凝治疗患者的协作式护士处方开具的有效性和健康结局：一项研究方案
Healthcare (Basel). 2024 Jan 30;12(3):347. doi: 10.3390/healthcare12030347.
7
Cost-Utility and Budget Impact Analysis of Implementing Anticoagulation Clinics and Point-of-Care Monitoring Devices in Anticoagulated Patients in Argentina.阿根廷抗凝患者中实施抗凝诊所和即时检测监测设备的成本效用及预算影响分析
Pharmacoecon Open. 2022 Sep;6(5):657-668. doi: 10.1007/s41669-022-00352-4. Epub 2022 Jul 14.
8
A clinical study of genetic testing to guide the dosing of warfarin after heart valve replacement.心脏瓣膜置换术后基于基因检测指导华法林剂量调整的临床研究。
BMC Cardiovasc Disord. 2022 Apr 19;22(1):183. doi: 10.1186/s12872-022-02620-x.
9
Therapeutic-Dose Warfarin (International Normalized Ratio >1.6) Plus Aspirin Improved Long-Term Patency of Saphenous Vein Graft without Bleeding Complication.治疗剂量华法林（国际标准化比值>1.6）联合阿司匹林可改善大隐静脉移植物通畅率而不增加出血并发症。
Ann Thorac Cardiovasc Surg. 2022 Feb 20;28(1):63-71. doi: 10.5761/atcs.oa.21-00236. Epub 2022 Jan 17.
10
Evaluation of Time in Therapeutic Range on Warfarin Therapy Between Face-to-Face and Telephone Follow-Up in a VA Medical Center.在一家退伍军人医疗中心，面对面随访与电话随访对华法林治疗的治疗范围内时间的评估
J Pharm Technol. 2015 Apr;31(2):78-83. doi: 10.1177/8755122514552497. Epub 2014 Oct 1.